Malaria Parasite Invasion and Host Cell Signaling
Author Information
Author(s): Sicard Audrey, Semblat Jean-Philippe, Doerig Caroline, Hamelin Romain, Moniatte Marc, Dorin-Semblat Dominique, Spicer Julie A, Srivastava Anubhav, Retzlaff Silke, Heussler Volker, Waters Andrew P, Doerig Christian
Primary Institution: INSERM U609/Inserm-EPFL Joint Laboratory, Global Health Institute
Hypothesis
Is the PAK-MEK signaling pathway activated in malaria parasite-infected erythrocytes?
Conclusion
The study found that the PAK-MEK signaling pathway is activated in malaria-infected red blood cells, and inhibiting this pathway can kill the parasites.
Supporting Evidence
- MEK inhibitors showed parasiticidal effects on both P. falciparum and P. berghei.
- Pharmacological interference with host MEK and PAK function resulted in parasite death.
- MEK1 phosphorylation was significantly higher in infected erythrocytes compared to uninfected ones.
- PAK1 is activated in infected erythrocytes, suggesting a critical role in parasite survival.
- Allosteric inhibitors of MEK and PAK have potential as antimalarial drugs.
Takeaway
When malaria parasites infect red blood cells, they trick the cells into activating a signaling pathway that helps them survive, but blocking this pathway can kill the parasites.
Methodology
The study used pharmacological inhibitors to block the PAK and MEK pathways in infected erythrocytes and measured the effects on parasite survival.
Potential Biases
Potential bias in the interpretation of pharmacological effects due to the specificity of inhibitors used.
Limitations
The study does not explore all potential pathways involved in parasite survival and the effects of inhibitors on other cellular processes.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website